Ayala Pharmaceuticals, Inc. (AYLA)
NASDAQ: AYLA · IEX Real-Time Price · USD
1.35
-0.01 (-0.74%)
At close: Aug 12, 2022 4:00 PM
1.38
+0.03 (2.22%)
After-hours:
Aug 12, 2022 7:52 PM EDT
Balance Sheet (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|
Cash & Equivalents
|
36.98 | 42.03 | 16.73 | 26.1 |
Short-Term Investments
|
0.12 | 0.09 | 0.08 | 0.17 |
Cash & Cash Equivalents
|
37.1 | 42.12 | 16.81 | 26.26 |
Cash Growth
|
-11.90% | 150.57% | -36.00% | - |
Receivables
|
0 | 0.68 | 0.47 | 0 |
Other Current Assets
|
2.64 | 1.44 | 0.42 | 0.59 |
Total Current Assets
|
39.74 | 44.24 | 17.69 | 26.85 |
Property, Plant & Equipment
|
1.12 | 1.28 | 1.42 | 0.24 |
Other Long-Term Assets
|
0.27 | 0.31 | 0.94 | 0.03 |
Total Long-Term Assets
|
1.39 | 1.59 | 2.36 | 0.27 |
Total Assets
|
41.13 | 45.83 | 20.05 | 27.13 |
Accounts Payable
|
6.47 | 6.88 | 5.3 | 2.77 |
Total Current Liabilities
|
6.47 | 6.88 | 5.3 | 2.77 |
Other Long-Term Liabilities
|
0.5 | 0.55 | 53.67 | 46.21 |
Total Long-Term Liabilities
|
0.5 | 0.55 | 53.67 | 46.21 |
Total Liabilities
|
6.97 | 7.43 | 58.97 | 48.98 |
Common Stock
|
145.3 | 109.29 | 1.82 | 1.09 |
Retained Earnings
|
-111.14 | -70.89 | -40.74 | -22.95 |
Shareholders' Equity
|
34.16 | 38.4 | -38.92 | -21.86 |
Total Liabilities and Equity
|
41.13 | 45.83 | 20.05 | 27.13 |
Net Cash / Debt
|
37.1 | 42.12 | 16.81 | 26.26 |
Net Cash / Debt Growth
|
-11.90% | 150.57% | -36.00% | - |
Net Cash Per Share
|
2.58 | 4.27 | 3.38 | 5.32 |
Working Capital
|
33.27 | 37.36 | 12.39 | 24.08 |
Book Value Per Share
|
2.37 | 3.89 | -7.82 | -4.43 |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).